Raymond Farah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Raymond Farah has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Hector Cohen
Department of Pathology, Western Galilee Hospital, Nahariya, Israel
3 shared publicationsFaris Nassar
Department of Internal Medicine E. Western Galilee Hospital, Nahariya, Israel
2 shared publicationsRon Reshef
2 shared publicationsWisam Sbeit
2 shared publicationsB. Kristal
1 shared publicationEleonora Vaisban
Department of Internal Medicine E. Western Galilee Hospital, Nahariya, Israel
1 shared publication
Latest Publications
- 5 November 2005
- Vol. 68 (3) , 392-3
Fatal acute sodium phosphate enemas intoxication.
We describe a patient who died as a result of severe hypocalcaemia and hyperphosphatemia after treatment with a sodium-phosphate enema. Physicians should be aware of the risk when using these enemas, even in normal doses, especially in elderly patients without signs of renal failure, as in our patient.
- 5 November 2005
- Vol. 68 (3) , 392-3
Fatal acute sodium phosphate enemas intoxication.
We describe a patient who died as a result of severe hypocalcaemia and hyperphosphatemia after treatment with a sodium-phosphate enema. Physicians should be aware of the risk when using these enemas, even in normal doses, especially in elderly patients without signs of renal failure, as in our patient.
- 28 February 2005
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 16 (1) , 56-58
A rare lung manifestation with rapidly progressive glomerulonephritis (RPGN)
- 28 February 2005
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 16 (1) , 56-58
A rare lung manifestation with rapidly progressive glomerulonephritis (RPGN)
- 1 February 2005
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 9 (1) , 46-48
Low-grade renal collecting duct carcinoma. A case report with histochemical, immunohistochemical, and ultrastructural study
- 1 February 2005
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 9 (1) , 46-48
Low-grade renal collecting duct carcinoma. A case report with histochemical, immunohistochemical, and ultrastructural study
- 1 January 2005
- Published by Dustri-Verlag Dr. Karl Feistle in Clinical Nephrology
- Vol. 63 (01) , 50-53
Light chain muscle deposition caused rhabdomyolysis and acute renal failure in patient with multiple myeloma
Case report of a 70-year-old woman with the diagnosis of multiple myeloma and acute renal failure due to rhabdomyolysis (RDM) that was caused from the deposition of kappa light chain in muscle fibers. In addition, the deposition was found in the liver.
- 1 January 2005
- Published by Dustri-Verlag Dr. Karl Feistle in Clinical Nephrology
- Vol. 63 (01) , 50-53
Light chain muscle deposition caused rhabdomyolysis and acute renal failure in patient with multiple myeloma
Case report of a 70-year-old woman with the diagnosis of multiple myeloma and acute renal failure due to rhabdomyolysis (RDM) that was caused from the deposition of kappa light chain in muscle fibers. In addition, the deposition was found in the liver.
- 1 September 2004
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 38 (9) , 1435-1438
Fatal Venous Thromboembolism Associated with Antipsychotic Therapy
OBJECTIVE: To describe the occurrence of pulmonary embolism (PE) as a rare adverse effect of clozapine that is treatable, but sometimes fatal, and survey the literature on the subject in the hope of increasing awareness of the potential danger that may result from drug interactions. CASE SUMMARY: A 47-year-old woman treated with clozapine and paroxetine was admitted to the hospital with dyspnea and swelling of the leg. The patient was diagnosed as having PE and was treated with intravenous heparin. On hospital day 7, sudden acute respiratory failure developed and the patient died. Postmortem examination confirmed the existence of massive PE. DISCUSSION: The woman had no identifiable risk factors other than receiving a combination of clozapine and paroxetine, with a demonstrated elevated clozapine blood concentration. Use of the Naranjo probability scale revealed a probable likelihood that the adverse reaction was drug related. CONCLUSIONS: The association of antipsychotic drugs and venous thromboembolism has been previously described, but is still a rare finding. This case highlights the importance of monitoring and possibly discontinuing treatment when venous thrombosis is suspected. There should be careful monitoring, especially in patients with risk factors for thrombosis. Finally, antidepressant—antipsychotic drug combinations can increase the risk of rare adverse effects, such as venous thromboembolism, even in the absence of other risk factors.
- 1 September 2004
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 38 (9) , 1435-1438
Fatal Venous Thromboembolism Associated with Antipsychotic Therapy
OBJECTIVE: To describe the occurrence of pulmonary embolism (PE) as a rare adverse effect of clozapine that is treatable, but sometimes fatal, and survey the literature on the subject in the hope of increasing awareness of the potential danger that may result from drug interactions. CASE SUMMARY: A 47-year-old woman treated with clozapine and paroxetine was admitted to the hospital with dyspnea and swelling of the leg. The patient was diagnosed as having PE and was treated with intravenous heparin. On hospital day 7, sudden acute respiratory failure developed and the patient died. Postmortem examination confirmed the existence of massive PE. DISCUSSION: The woman had no identifiable risk factors other than receiving a combination of clozapine and paroxetine, with a demonstrated elevated clozapine blood concentration. Use of the Naranjo probability scale revealed a probable likelihood that the adverse reaction was drug related. CONCLUSIONS: The association of antipsychotic drugs and venous thromboembolism has been previously described, but is still a rare finding. This case highlights the importance of monitoring and possibly discontinuing treatment when venous thrombosis is suspected. There should be careful monitoring, especially in patients with risk factors for thrombosis. Finally, antidepressant—antipsychotic drug combinations can increase the risk of rare adverse effects, such as venous thromboembolism, even in the absence of other risk factors.
- 1 September 2003
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 15 (9) , 1029-1031
Cytomegalovirus colitis and haemolytic anaemia in a glucose-6-phosphate dehydrogenase-deficient immunocompetent patient
- 1 September 2003
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 15 (9) , 1029-1031
Cytomegalovirus colitis and haemolytic anaemia in a glucose-6-phosphate dehydrogenase-deficient immunocompetent patient
- 1 September 2001
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 35, 1049-1052
Nimesulide-Induced Acute Hepatitis
- 1 September 2001
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 35, 1049-1052
Nimesulide-Induced Acute Hepatitis